Ziprasidone Hydrochloride
NDC Package 63187-168-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Ziprasidone Hydrochloride is capsules are indicated for the treatment of schizophrenia. Marketed by Proficient Rx Lp, this product is identified by NDC 63187-168 and is authorized under FDA application ANDA077562.

Identification & Billing

NDC Package Code
63187-168-60
Package Description
60 CAPSULE in 1 BOTTLE
Product Code
63187-168
11-Digit Billing Format
63187016860

Clinical Specifications

Proprietary Name
Ziprasidone Hydrochloride
Dosage Form
-
Usage Information
Ziprasidone hydrochloride capsules are indicated for the treatment of schizophrenia. When deciding among the alternative treatments available for the condition needing treatment, the prescriber should consider the finding of ziprasidone's greater capacity to prolong the QT/QTc interval compared to several other antipsychotic drugs [see WARNINGS AND PRECAUTIONS (5.2)]. Prolongation of the QTc interval is associated in some other drugs with the ability to cause torsade de pointes-type arrhythmia, a potentially fatal polymorphic ventricular tachycardia, and sudden death. In many cases this would lead to the conclusion that other drugs should be tried first. Whether ziprasidone will cause torsade de pointes or increase the rate of sudden death is not yet known [see WARNINGS AND PRECAUTIONS (5.2)]

Regulatory & Marketing

Labeler Name
Proficient Rx Lp
FDA Application #
ANDA077562
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-13-2013
End Marketing Date
11-30-2025
Listing Expiration
11-30-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (63187-168). Click a package code to view its specific billing and regulatory data.

63187-168-30
30 CAPSULE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63187-168-60 identifies a specific commercial package of 60 capsule in 1 bottle of Ziprasidone Hydrochloride, labeled by Proficient Rx Lp. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Proficient Rx Lp on February 13, 2013. The current certification is valid through November 30, 2025.

How is this Proficient Rx Lp product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63187016860. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
63187-168-60
11-Digit CMS (5-4-2)
63187-0168-60

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.